Cargando…
Serum level of IFNβ distinguishes early from late relapses after biologics withdrawal in rheumatoid arthritis
Since the advent of biological disease modifying anti-rheumatic drugs (bDMARDs) in the treatment of rheumatoid arthritis (RA), most RA patients receiving such drugs have achieved remission at the expense of cost and infection risk. After bDMARDs are withdrawn, a substantial proportion of patients wo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529916/ https://www.ncbi.nlm.nih.gov/pubmed/36192530 http://dx.doi.org/10.1038/s41598-022-21160-0 |